NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.
Daly M, Pilarski R, Berry M, Buys S, Farmer M, Friedman S, Garber J, Kauff N, Khan S, Klein C, Kohlmann W, Kurian A, Litton J, Madlensky L, Merajver S, Offit K, Pal T, Reiser G, Shannon K, Swisher E, Vinayak S, Voian N, Weitzel J, Wick M, Wiesner G, Dwyer M, Darlow S. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017. Journal Of The National Comprehensive Cancer Network 2016, 15: 9-20. PMID: 28040716, DOI: 10.6004/jnccn.2017.0003.Peer-Reviewed Original ResearchMeSH KeywordsFemaleGenetic CounselingGenetic TestingHereditary Breast and Ovarian Cancer SyndromeHumansMutationPractice Guidelines as TopicRisk AssessmentRisk FactorsConceptsGenetic/Familial High-Risk AssessmentHigh-risk assessmentOvarian cancerNCCN Clinical Practice GuidelinesNCCN Guidelines InsightsClinical practice guidelinesRisk of breastHereditary cancer syndromesPenetrant genetic mutationsMost recent recommendationsRelevant new dataPractice guidelinesCancer syndromesGenetic testingBreastSyndromeRecent recommendationsGenetic mutationsCancerManagement recommendationsRisk management recommendationsGuidelinesAssessmentPatientsRecommendations